Advertisement
AFL vs MET
Which Stock Would AI Choose? Aflac (AFL) vs. MetLife (MET) Stock Comparison
Key Takeaways
- Aflac Incorporated (AFL) and MetLife, Inc. (MET) are both large-cap insurers, but they compete in different segments: Aflac specializes in supplemental health and accident coverage, while MetLife is a diversified global life insurer and asset manager.
- MetLife has shown stronger recent momentum, with a year-to-date gain of roughly 29% versus approximately 14% for Aflac, and a materially lower forward price-to-earnings multiple.
- MetLife's earnings have been beating consensus estimates on higher investment income and volume growth, while Aflac has faced softer top-line trends, Japan premium pressure, and recent cybersecurity-related concerns.
- Tickeron AI Verdict: MET — based on observable trend consistency, relative momentum, and analyst positioning, Tickeron's AI currently favors MetLife over Aflac.
- For deeper coverage, explore AFL Major News, AFL Today's Price Move, MET Major News, and MET Today's Price Move.
- To see which strategies AI trading bots are running right now, visit Trending AI Robots.
Introduction
Insurance stocks often attract investors seeking steady cash flow, dividends, and defensive characteristics, yet the segment is far from uniform. AFL (Aflac) is best known for supplemental health and accident policies, with a heavy concentration in Japan, while MET (MetLife) operates as a diversified global life insurer spanning group benefits, retirement, and asset management. This stock comparison is relevant for income-oriented investors and traders evaluating relative performance, valuation, and market positioning between two insurance giants. Recent market activity has created a clear divergence in momentum and sentiment, making a head-to-head review timely for anyone weighing these two names against each other.
AFL Overview and Recent Performance
Aflac Incorporated, headquartered in Columbus, Georgia, generates the majority of its earnings from supplemental insurance products sold in Japan and the United States. The company has long been prized for its capital-return discipline, with steady dividends and substantial share buybacks supporting per-share results. In recent weeks, however, Aflac's shares have traded below their 52-week high, reflecting a more cautious tone. Recent earnings reports have missed consensus estimates, with adjusted revenues pressured by softer investment income and foreign-exchange effects, even as the U.S. segment posted modest sales growth. Analysts have also flagged Japan premium pressure and the fallout from a cybersecurity incident as factors weighing on sentiment. The consensus rating for AFL sits around Hold, and the stock's lower beta reflects its historically defensive, lower-volatility profile.
MET Overview and Recent Performance
MetLife, Inc., based in New York, is one of the largest life insurers globally, organized around group benefits, retirement and income solutions (RIS), Asia, Latin America, EMEA (Europe, the Middle East, and Africa), and MetLife Investment Management. In recent market activity, MetLife's stock has outperformed the broader market, supported by stronger-than-expected quarterly results. Adjusted earnings per share rose about 23% year over year, aided by higher net investment income, favorable underwriting, and solid volume growth across Group Benefits, Asia, and EMEA. Wall Street sentiment has been constructive, with several firms raising price targets and a consensus rating of Buy. This combination of earnings beats and analyst upgrades has reinforced MET's relative strength, though its higher beta means somewhat greater sensitivity to market swings.
Trending AI Robots
For traders who prefer a systematic, data-driven approach, Tickeron's Trending AI Robots page offers a curated view of the platform's most relevant automated strategies. Tickeron hosts hundreds of AI trading bots that monitor thousands of tickers, but only a select group earns a place in this section based on their fit with current market conditions. These bots vary widely in trading style, strategy, timeframe, performance statistics, and the sets of tickers they trade — ranging from short-term momentum systems to longer-horizon swing approaches. Rather than sifting through every available bot, investors can focus on the strategies currently drawing attention. Exploring the Trending AI Robots page is a practical way to see how automated tools are positioning across names like AFL and MET right now.
Head-to-Head Comparison
The two companies diverge most clearly in business model and geographic exposure. Aflac is concentrated in Japan and supplemental health coverage, which gives it niche depth but ties its results to Japanese interest rates and currency moves. MetLife, by contrast, is more diversified across product lines and regions, which spreads risk but also introduces complexity from pension risk transfers and investment portfolio sensitivity. On valuation, the contrast is striking: MetLife trades at a forward P/E (price-to-earnings) ratio below 10, while Aflac's forward multiple is materially higher, a gap that reflects MetLife's faster earnings growth against Aflac's slower revenue trajectory. Momentum also favors MetLife, whose year-to-date and one-year returns roughly double Aflac's. Risk factors differ too: Aflac faces Japan-specific and cybersecurity overhangs, while MetLife carries greater interest-rate and credit-market sensitivity given its larger investment portfolio and heavier use of leverage. Sentiment, as measured by analyst ratings and recent price-target revisions, is currently more positive for MetLife.
Tickeron AI Verdict
Weighing trend consistency, relative momentum, valuation, and the direction of recent catalysts, Tickeron's AI currently leans toward MET in this pairing. MetLife's combination of accelerating earnings, a lower forward multiple, and a more favorable analyst posture gives it the clearer near-term edge, while Aflac's softer revenue trends and Japan-related headwinds temper its relative appeal. That said, this is a probabilistic read on current conditions rather than a definitive forecast, and Aflac's defensive, lower-volatility profile may still suit more conservative investors. As always, the balance of evidence can shift as new earnings data and market catalysts emerge.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AFL is a StrongBuy and MET is a StrongBuy.
Momentum Indicator for AFL turns positive, indicating new upward trend
AFL saw its Momentum Indicator move above the 0 level on October 08, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 76 similar instances where the indicator turned positive. In 47 of the 76 cases, the stock moved higher in the following days. The odds of a move higher are at 62%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Moving Average Convergence Divergence (MACD) for AFL just turned positive on October 07, 2026. Looking at past instances where AFL's MACD turned positive, the stock continued to rise in 26 of 46 cases over the following month. The odds of a continued upward trend are 57%.
AFL moved above its 50-day moving average on October 14, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for AFL crossed bullishly above the 50-day moving average on October 20, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 8 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 50%.
Following a +1.51% 3-day Advance, the price is estimated to grow further. Considering data from situations where AFL advanced for three days, in 200 of 365 cases, the price rose further within the following month. The odds of a continued upward trend are 55%.
The Aroon Indicator entered an Uptrend today. In 141 of 277 cases where AFL Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 51%.
Bearish Trend Analysis
The RSI Oscillator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 29 of 64 cases where AFL's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 45%.
AFL broke above its upper Bollinger Band on October 16, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Profit vs. Risk Rating rating for this company is 3 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 60, placing this stock better than average.
The Tickeron Price Growth Rating for this company is 32 (best 1 - 100 worst), indicating outstanding price growth. AFL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 59 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 77 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.052) is normal, around the industry mean (1.337). P/E Ratio (13.325) is within average values for comparable stocks, (19.773). Projected Growth (PEG Ratio) (0.060) is also within normal values, averaging (0.463). Dividend Yield (0.020) settles around the average of (0.047) among similar stocks. AFL's P/S Ratio (3.313) is slightly higher than the industry average of (1.303).
The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
MET in +1.25% Uptrend, growing for three consecutive days on November 11, 2026
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where MET advanced for three days, in 229 of 346 cases, the price rose further within the following month. The odds of a continued upward trend are 66%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 34 of 55 cases where MET's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 62%.
The Momentum Indicator moved above the 0 level on November 06, 2026. You may want to consider a long position or call options on MET as a result. In 45 of 84 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 54%.
The Moving Average Convergence Divergence (MACD) for MET just turned positive on November 10, 2026. Looking at past instances where MET's MACD turned positive, the stock continued to rise in 32 of 53 cases over the following month. The odds of a continued upward trend are 60%.
MET moved above its 50-day moving average on October 08, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for MET crossed bullishly above the 50-day moving average on October 13, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 9 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 60%.
The Aroon Indicator entered an Uptrend today. In 153 of 283 cases where MET Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 54%.
Bearish Trend Analysis
The 10-day RSI Indicator for MET moved out of overbought territory on October 23, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 47 similar instances where the indicator moved out of overbought territory. In 20 of the 47 cases, the stock moved lower in the following days. This puts the odds of a move lower at 43%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MET declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 51%.
MET broke above its upper Bollinger Band on October 12, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 15 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 20 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 60, placing this stock better than average.
The Tickeron Price Growth Rating for this company is 24 (best 1 - 100 worst), indicating outstanding price growth. MET’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 55 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: MET's P/B Ratio (2.276) is slightly higher than the industry average of (1.337). P/E Ratio (18.683) is within average values for comparable stocks, (19.773). Projected Growth (PEG Ratio) (0.506) is also within normal values, averaging (0.463). Dividend Yield (0.024) settles around the average of (0.047) among similar stocks. P/S Ratio (0.824) is also within normal values, averaging (1.303).
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
AFL | MET | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 41 | 29 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 77 Overvalued | 55 Fair valued | |
PROFIT vs RISK RATING 1..100 | 3 | 20 | |
SMR RATING 1..100 | 94 | 99 | |
PRICE GROWTH RATING 1..100 | 32 | 24 | |
P/E GROWTH RATING 1..100 | 59 | 15 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
MET's Valuation (55) in the Life Or Health Insurance industry is in the same range as AFL (77). This means that MET’s stock grew similarly to AFL’s over the last 12 months.
AFL's Profit vs Risk Rating (3) in the Life Or Health Insurance industry is in the same range as MET (20). This means that AFL’s stock grew similarly to MET’s over the last 12 months.
AFL's SMR Rating (94) in the Life Or Health Insurance industry is in the same range as MET (99). This means that AFL’s stock grew similarly to MET’s over the last 12 months.
MET's Price Growth Rating (24) in the Life Or Health Insurance industry is in the same range as AFL (32). This means that MET’s stock grew similarly to AFL’s over the last 12 months.
MET's P/E Growth Rating (15) in the Life Or Health Insurance industry is somewhat better than the same rating for AFL (59). This means that MET’s stock grew somewhat faster than AFL’s over the last 12 months.
| AFL | MET | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 50% | 1 day ago 43% |
| Stochastic ODDS (%) | 1 day ago 45% | 1 day ago 62% |
| Momentum ODDS (%) | 3 days ago 62% | 1 day ago 54% |
| MACD ODDS (%) | 6 days ago 57% | 1 day ago 60% |
| TrendWeek ODDS (%) | 1 day ago 57% | 1 day ago 61% |
| TrendMonth ODDS (%) | 1 day ago 53% | 1 day ago 54% |
| Advances ODDS (%) | 1 day ago 55% | 1 day ago 66% |
| Declines ODDS (%) | N/A | 6 days ago 51% |
| BollingerBands ODDS (%) | 1 day ago 43% | 1 day ago 47% |
| Aroon ODDS (%) | 1 day ago 51% | 1 day ago 54% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
AFL’s FA Score shows that 2 FA rating(s) are green while MET’s FA Score has 3 green FA rating(s).
- AFL’s FA Score: 2 green, 3 red.
- MET’s FA Score: 3 green, 2 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
AFL’s TA Score shows that 6 TA indicator(s) are bullish while MET’s TA Score has 7 bullish TA indicator(s).
- AFL’s TA Score: 6 bullish, 3 bearish.
- MET’s TA Score: 7 bullish, 3 bearish.
Price Growth
AFL (@Life/Health Insurance) experienced а +1.44% price change this week, while MET (@Life/Health Insurance) price change was +0.05% for the same time period.
The average weekly price growth across all stocks in the @Life/Health Insurance industry was +0.56%. For the same industry, the average monthly price growth was +3.48%, and the average quarterly price growth was -0.70%.
Reported Earning Dates
AFL is expected to report earnings on Feb 03, 2027.
MET is expected to report earnings on Feb 03, 2027.
Industries' Descriptions
@Life/Health Insurance (+0.56% weekly)Life insurance companies mainly sell policies that pay a death benefit as a lump sum upon the death of the insured to their beneficiaries. Life insurance policies may be sold as term life, (which guarantees payment of a stated death benefit and expires at the end of a specified term) or permanent /typically whole life (which is more expensive but lasts a lifetime and carries a cash accumulation component). Life insurance firms may also sell long-term disability policies that help to replace the insured individual’s income if they become sick or disabled. Health insurance, on the other hand, helps pay for medical expenses. Anthem, Inc., MetLife, Inc. and Aflac Incorporated are some of the largest U.S. companies in this industry.
Advertisement
AFL and
Correlation & Price change
A.I.dvisor indicates that over the last year, AFL has been loosely correlated with CNO. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if AFL jumps, then CNO could also see price increases.
MET and
Correlation & Price change
A.I.dvisor indicates that over the last year, MET has been closely correlated with PRU. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if MET jumps, then PRU could also see price increases.